Novartis Aktie
97,82
EUR
-0,02
EUR
-0,02
%
91,55
CHF
±0,00
CHF
±0,00
%
Werbung
Novartis Aktie Analyse
29.05.19 | Novartis Underweight | JP Morgan Chase & Co. | |
28.05.19 | Novartis Neutral | Credit Suisse Group | |
28.05.19 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
27.05.19 | Novartis Neutral | UBS AG | |
27.05.19 | Novartis Hold | Deutsche Bank AG | |
24.05.19 | Novartis Neutral | UBS AG | |
24.05.19 | Novartis Underweight | JP Morgan Chase & Co. | |
21.05.19 | Novartis buy | Kepler Cheuvreux | |
Werbung
|
|||
17.05.19 | Novartis Neutral | Credit Suisse Group | |
16.05.19 | Novartis buy | Jefferies & Company Inc. | |
16.05.19 | Novartis Neutral | UBS AG | |
09.05.19 | Novartis Underweight | JP Morgan Chase & Co. | |
07.05.19 | Novartis Hold | Deutsche Bank AG | |
06.05.19 | Novartis Underweight | JP Morgan Chase & Co. | |
25.04.19 | Novartis Neutral | Credit Suisse Group | |
25.04.19 | Novartis Hold | Deutsche Bank AG | |
25.04.19 | Novartis Hold | HSBC | |
25.04.19 | Novartis buy | Jefferies & Company Inc. | |
25.04.19 | Novartis Underweight | JP Morgan Chase & Co. | |
24.04.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
24.04.19 | Novartis Neutral | UBS AG | |
24.04.19 | Novartis Underweight | JP Morgan Chase & Co. | |
17.04.19 | Novartis Underweight | JP Morgan Chase & Co. | |
17.04.19 | Novartis buy | Jefferies & Company Inc. | |
16.04.19 | Novartis buy | Kepler Cheuvreux | |
12.04.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
10.04.19 | Novartis Underweight | Barclays Capital | |
10.04.19 | Novartis Underweight | Morgan Stanley | |
08.04.19 | Novartis Underweight | JP Morgan Chase & Co. | |
08.04.19 | Novartis Underweight | Barclays Capital | |
05.04.19 | Novartis Neutral | Credit Suisse Group | |
05.04.19 | Novartis Hold | Deutsche Bank AG | |
03.04.19 | Novartis Underweight | JP Morgan Chase & Co. | |
27.03.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
27.03.19 | Novartis buy | Jefferies & Company Inc. | |
25.03.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
04.03.19 | Novartis Neutral | UBS AG | |
26.02.19 | Novartis Underweight | JP Morgan Chase & Co. | |
06.02.19 | Novartis Hold | HSBC | |
04.02.19 | Novartis Hold | Deutsche Bank AG | |
01.02.19 | Novartis Underweight | Barclays Capital | |
01.02.19 | Novartis Underweight | JP Morgan Chase & Co. | |
31.01.19 | Novartis Neutral | Credit Suisse Group | |
31.01.19 | Novartis Underweight | JP Morgan Chase & Co. | |
31.01.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
30.01.19 | Novartis Hold | Deutsche Bank AG | |
30.01.19 | Novartis Neutral | UBS AG | |
30.01.19 | Novartis buy | Kepler Cheuvreux | |
30.01.19 | Novartis buy | Jefferies & Company Inc. | |
29.01.19 | Novartis Underweight | JP Morgan Chase & Co. |
Werbung
Werbung